期刊文献+

冠状动脉支架术后支架内亚急性血栓形成(附5例报告) 被引量:1

Subacute thrombosis in coronary stents after percutaneous coronary intervention:report of 5 cases
下载PDF
导出
摘要 目的评价和探讨支架内亚急性血栓(SAT)的发生机制和预防。方法随访和分析2004-2007年5例冠心病患者支架置入术后发生SAT患者的临床和冠脉造影特点。结果(1)在529例冠心病支架置入患者中有5例(0.94%)发生SAT,多于术后2~5d出现。其中3例冠脉造影证实SAT,积极治疗后6个月冠脉造影随访支架内无再狭窄;2例可能为SAT;死亡2例,1例在院外死亡,均为未及时介入治疗。(2)上述5例患者中3例表现为ST抬高型心肌梗死,1例表现为急性左心衰,心源性休克,1例表现为不稳定性心绞痛。4例患者为药物洗脱支架后SAT,1例为裸支架后SAT。结论支架内SAT可能与C型病变,术中支架贴壁不良,急性心肌梗死有关,及时介入治疗可以减少不良后果的发生。 Objective To study the pathogenesis and prevention of subacute thrombosis (SAT) in coronary stents after percutaneous coronary intervention. Methods We reviewed 529 patients who underwent percutaneous coronary intervention (PCI) from January 2004 to August 2007. Among them,5 patients represented SAT associated with coronary stents. The clinical data and angiography results and anti-thrombus treatment of these 5 patients were analyzed. Results (1) The incidence of SAT was 0.94% (5/529),and it mostly presented at 2-5 d after PCI. Three patients had definite stent thrombosis,and coronary angiography showed no stent restenosis after active treatment for 6 months. Two patients had probable stent thrombosis. Two patients died,one in hospital and one after discharge,both due to absence of timely intervention therapy. (2) Among 5 SAT cases,3 patients represented ST-elevation myocardial infarction,1 represented acute left heart failure and cardiogenic shock,1 represented unstable angina. Four patients represented SAT associated with use of drug-eluting stent,and 1 represented SAT associated with use of bare stents. Conclusion SAT may be related to intraoperative stent malposition,acute myocardial infarction,diabetes and C-type diseases. Timely intervention therapy can reduce the hazard for SAT.
出处 《中华老年多器官疾病杂志》 2010年第1期34-37,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 冠状动脉疾病 支架 血栓形成 coronary heart disease stent thrombosis
  • 相关文献

参考文献11

  • 1Trabattoni D,Fabbiocchi F,Montorsi P,et al.Stent thrombosis after sirolimus-and paclitaxel-eluting stent implantation in daily clinical practice:analysis of a single center registry[J].Catheter Cardiovasc Interv,2007,70(3):415-421.
  • 2Buonamici P,Marcucci R,Migliorini A,et al.Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis[J].J Am Coll Cardiol,2007,49(24):2312-2319.
  • 3Machecourt J,Danchin N,Lablanche JM,et al.Risk factors for stem thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients:the EVASTENT Matched-Cohort[J].J Am Coll Cardiol,2007,50(6):501-508.
  • 4韩雅君,王伟民.冠状动脉支架内血栓形成[J].中华老年心脑血管病杂志,2005,7(5):351-352. 被引量:13
  • 5De la Torre-Hernandez JM,Alfonso F,Hernandez F,et al.Drug-eluting stent thrombosis:results from the multicenter Spanish registry ESTROFA[J].J Am Coll Cardiol,2008,51(10):986-990.
  • 6Mauri L,Hsieh WH,Massaro JM,et al.Stent thrombosis in randomized clinical trials of drug-eluting stents[J].N Engl J Med,2007,356(10):1020-1029.
  • 7Yan BP,Duffy SJ,Clark DJ,et al.Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry)[J].Am J Cardiol,2008,101(12):1716-1722.
  • 8Cutlip DE,Windecker S,Mehran R,et al.Clinical end points in coronary stent trials:a case for standardized definitions[J].Circulation,2007,115(17):2344-2351.
  • 9Roy P,Torguson R,Okabe T,et al.Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents[J].J Interv Cardiol,2007,20(5):307-313.
  • 10Cutlip DE,Baim DS,Ho KK,et al.Stent thrombosis in the modern era:a pooled analysis of muhicenter coronary stem clinical trials[J].Circulation,2001,103(15):1967-1971.

二级参考文献14

  • 1Farb A, Burke AP, Kolodgie FD, et al . Pathological mechanisms of fatal late coronary stent thrombosis in humans[Jl. Circulation,2003,108:1701-1706.
  • 2Frab A, Sangiorgi G, Carter AJ, et al . Pathology of acute and chronic tissue response to coronary stenting in humans[J]. Circulation, 1999,99:44-52.
  • 3Neumarm FJ, Ott I, Gawaz M, et al , Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty[J]. J Am Coll Cardiol, 1996,27:819-824.
  • 4Gawaz M, Neumann FJ, Ott I, et al . Role of activation-dependent platelet membrane glycoproteins in development of subacute occlusive coronary stent thrombosis[J]. Coron Artery Dis, 1997, 8:121-128.
  • 5Neumann FJ, Gawaz M, Ott I, et al . Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schaz stenting[J]. J Am Coil Cardiol, 1996, 27:15-21.
  • 6Moussa I. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation[ J]. Circulation, 1999,99 : 2364-2366.
  • 7Sehulen H, Kastrati A, Dirschinger J, et al . Intracoronary stenting and risk for major adverse cardiac events during the first month[Jl.Circulation, 1998,98:104-111.
  • 8Cheneau E, Leborgne L, Mintz GS, et al . Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study[J]. Circulation, 2003, 108:43-47.
  • 9Honda Y, Fitzgerald PJ. Stent thrombosis-an issue revisited in a changing world[J]. Circulation, 2003, 108:2-5.
  • 10Gurbel PA, Callahan KP, Malinin AL, et al . Could stent design affect platelet activation? Results of the Platelet Activation in Stenting(PAST) study[J]. J Inves Cardiol, 2002, 14:584-589.

共引文献12

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部